Allogeneic hematopoietic cell transplantation with double alkylating agents containing reduced-intensity conditioning for patients ⩾60 years with advanced AML/MDS

Saved in:
Bibliographic Details
Published in:Leukemia 2016-12, Vol.30 (12), p.2426-2429
Main Authors: Bertz, H, Lübbert, M, Ohneberg, K, Zeiser, R, Wäsch, R, Marks, R, Finke, J
Format: Article
Language:English
Subjects:
Alkylating agents
Alkylation
Blood
Bone marrow
Cancer therapies
Disease prevention
Graft versus host disease
Leukemia
Medical prognosis
Mutation
Myelodysplastic syndromes
Remission (Medicine)
Stem cells
Transplantation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0887-6924
1476-5551
DOI:10.1038/leu.2016.248